PNEUMOCOCCAL CONJUGATE VACCINE - SCIENCE AND TECHNOLOGY

News: Only 61% of Tamil Nadu’s PCV requirement supplied during 2022

 

What's in the news?

       As against the annual requirement of 30 lakh doses of Pneumococcal Conjugate Vaccines (PCVs), Tamil Nadu received only a little over half of its requirement - 18 lakh doses during 2022, up to January 6, 2023.

 

Pneumococcal Conjugate Vaccine:

       It is used to protect infants, young children and adults against disease caused by the bacterium Streptococcus pneumoniae (pneumococcus).

       Conjugate: It is a type of vaccine that joins a protein to an antigen in order to improve the protection that vaccine provides.

       It contains purified capsular polysaccharide of pneumococcal serotypes conjugated to a carrier protein to improve antibody response.

       The unique feature of the PCV is its composition which is specially tailored to the prevailing serotype prevalence of S Pneumoniae in India and other regions of the world.

       There are three pneumococcal conjugate vaccines (PCV13, PCV15, and PCV20). The different vaccines are recommended for different people based on their age and medical status.

 

Go back to basics:

Pneumococcal disease:

       Pneumococcal disease refers to any illness caused by pneumococcal bacteria.

       These bacteria can cause many types of illnesses, including pneumonia, which is an infection of the lungs. 

       Pneumococcal bacteria are one of the most common causes of pneumonia.

       Besides pneumonia, pneumococcal bacteria can also cause:

       Ear infections

       Sinus infections

       Meningitis (infection of the tissue covering the brain and spinal cord)

       Bacteremia (infection of the blood).

 

Who are all at risk?

       Anyone can get pneumococcal disease, but children under 2 years old, people with certain medical conditions or other risk factors, and adults 65 years or older are at the highest risk.

       Most pneumococcal infections are mild. However, some can result in long-term problems, such as brain damage or hearing loss. Meningitis, bacteremia, and pneumonia caused by pneumococcal disease can be fatal.

 

Universal Immunization Programme:

       Universal Immunization Programme (UIP) is one of the largest public health programmes targeting close to 26.7 million newborns and 29 million pregnant women annually.

       Under UIP, immunization is being provided free of cost against 12 vaccine preventable diseases:

       Nationally against 10 diseases - Diphtheria, Pertussis, Tetanus, Polio, Measles, Rubella, severe form of Childhood Tuberculosis, Rotavirus diarrhea, Hepatitis B and Meningitis & Pneumonia caused by Haemophilus Influenzae type B.

       Sub-nationally against 2 diseases -  Pneumococcal Pneumonia and Japanese Encephalitis; of which Pneumococcal Conjugate vaccine is nationally expanded today, while JE vaccine is provided only in endemic districts.